Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial / Suciu, S.; Mandelli, F.; DE WITTE, T.; Zittoun, R.; Gallo, E.; Labar, B.; DE ROSA, Gennaro; Belhabri, A.; Giustolisi, R.; Delarue, R.; Liso, V.; Bourhis, J. H.. - In: BLOOD. - ISSN 0006-4971. - 102(4):(2003), pp. 1232-40.
Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial
DE ROSA, GENNARO;
2003
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
